Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth B Hirsch

Showing results (51-60 of 74) with videos related to

Pageof 8
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 21, 2011
Significant publications on infectious diseases pharmacotherapy in 2010Elizabeth B Hirsch, Jessica M Cottreau, Judy O Ikwuagwu, et al.
Diagnostic Microbiology and Infectious Disease|May 25, 2017
Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecyclineAlice Chen, Kenneth P Smith, Betsy A Whitfield, et al.
Plos One|December 1, 2015
Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. BacteremiaLauren R Biehle, Jessica M Cottreau, David J Thompson, et al.
Journal of Clinical Microbiology|July 17, 2020
Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa IsolatesElizabeth C Smith, Hunter V Brigman, Jadyn C Anderson, et al.
ACS Infectious Diseases|September 15, 2016
Progress against Escherichia coli with the Oxazolidinone Class of Antibacterials: Test Case for a General Approach To Improving Whole-Cell Gram-Negative ActivityKhuloud Takrouri, Harold D Cooper, Andrew Spaulding, et al.
Open Forum Infectious Diseases|December 21, 2022
Minnesota One Health Antibiotic Stewardship Collaborative: A Reproducible Approach to Facilitate Antimicrobial Stewardship ProgressEmma R Bollig, Elizabeth B Hirsch, Irene Bueno, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 27, 2026
Cost avoidance analysis of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation for patients enrolled in value-based payment models at an academic hospitalJennifer K Ross, Kimberly D Boeser, Matthew Hordyk, et al.
American Journal of Infection Control|August 29, 2017
Nasal methicillin-resistant Staphylococcus aureus screening in patients with pneumonia: A powerful antimicrobial stewardship toolEthan A Smith, Howard S Gold, Monica V Mahoney, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2017
Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activityAndrew Spaulding, Khuloud Takrouri, Pornachandran Mahalingam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2025
Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 SeropositivityAlyssa Christensen, Zachary Nelson, Sally Gustafson, et al.
Pageof 8

Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|October 21, 2011
Significant publications on infectious diseases pharmacotherapy in 2010Elizabeth B Hirsch, Jessica M Cottreau, Judy O Ikwuagwu, et al.
Diagnostic Microbiology and Infectious Disease|May 25, 2017
Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecyclineAlice Chen, Kenneth P Smith, Betsy A Whitfield, et al.
Plos One|December 1, 2015
Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. BacteremiaLauren R Biehle, Jessica M Cottreau, David J Thompson, et al.
Journal of Clinical Microbiology|July 17, 2020
Performance of Four Fosfomycin Susceptibility Testing Methods against an International Collection of Clinical Pseudomonas aeruginosa IsolatesElizabeth C Smith, Hunter V Brigman, Jadyn C Anderson, et al.
ACS Infectious Diseases|September 15, 2016
Progress against Escherichia coli with the Oxazolidinone Class of Antibacterials: Test Case for a General Approach To Improving Whole-Cell Gram-Negative ActivityKhuloud Takrouri, Harold D Cooper, Andrew Spaulding, et al.
Open Forum Infectious Diseases|December 21, 2022
Minnesota One Health Antibiotic Stewardship Collaborative: A Reproducible Approach to Facilitate Antimicrobial Stewardship ProgressEmma R Bollig, Elizabeth B Hirsch, Irene Bueno, et al.
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE|April 27, 2026
Cost avoidance analysis of outpatient parenteral antimicrobial therapy (OPAT) plan reconciliation for patients enrolled in value-based payment models at an academic hospitalJennifer K Ross, Kimberly D Boeser, Matthew Hordyk, et al.
American Journal of Infection Control|August 29, 2017
Nasal methicillin-resistant Staphylococcus aureus screening in patients with pneumonia: A powerful antimicrobial stewardship toolEthan A Smith, Howard S Gold, Monica V Mahoney, et al.
Bioorganic & Medicinal Chemistry Letters|November 6, 2017
Compound design guidelines for evading the efflux and permeation barriers of Escherichia coli with the oxazolidinone class of antibacterials: Test case for a general approach to improving whole cell Gram-negative activityAndrew Spaulding, Khuloud Takrouri, Pornachandran Mahalingam, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 25, 2025
Into the Unknown: Practical Remdesivir Restriction in the Era of Widespread SARS-CoV-2 SeropositivityAlyssa Christensen, Zachary Nelson, Sally Gustafson, et al.
Pageof 8